Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.09% | -34.23% | 10.50% | 18.35% | -4.95% |
| Total Depreciation and Amortization | 1.61% | 1.64% | 54.43% | -17.71% | -26.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -50.85% | -83.97% | 3,445.45% | -184.62% |
| Change in Net Operating Assets | 178.93% | 447.87% | -147.08% | 225.84% | -121.50% |
| Cash from Operations | 5.65% | -9.23% | -6.99% | 33.80% | -73.36% |
| Capital Expenditure | -651.58% | 89.06% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -833.33% | 91.19% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -10.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 6,694.48% | -97.22% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 5,989.12% | -96.66% | 371,220.00% | -100.03% | 338,200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 499.52% | -171.08% | 253.04% | -202.55% | 211.91% |